
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
Danny R. Johnson, RPh, describes the changes he's seen in the pharmacy profession over his career.
Danny R. Johnson, RPh, describes the changes he's seen in the pharmacy profession over his career.






